📉 The Financial Deep Dive
Neogen Chemicals Limited's financial results for the third quarter and nine months ended December 31, 2025, paint a concerning picture of declining profitability amidst stable revenue growth.
The Numbers:
- Standalone Q3 FY26: Revenue from operations rose 7.5% YoY to ₹215.60 crore. However, Profit After Tax (PAT) saw a steep 39% YoY decline, falling to ₹8.77 crore from ₹14.41 crore in Q3 FY25.
- Consolidated Q3 FY26: Revenue grew 9.2% YoY to ₹220.02 crore. PAT experienced a severe 63% YoY drop, settling at ₹3.69 crore compared to ₹10.01 crore in the prior year's quarter.
- Nine-Month Period (9M FY26): Standalone PAT decreased 25% YoY to ₹32.30 crore, while consolidated PAT fell 46.5% YoY to ₹17.33 crore.
The Quality:
Operating margins for standalone results remained steady at 17%. However, net profit margins compressed significantly, with standalone at 4% and consolidated at a mere 2%. This stark contrast between operating and net margins suggests a substantial impact from higher finance costs or other non-operating expenses on the bottom line.
The Grill:
While no direct analyst-management 'grill' was detailed in the filing, the independent auditor's report on the company's listed Non-Convertible Debentures (NCDs) serves as a major point of concern. The auditor's certificate explicitly stated that Neogen Chemicals Limited has not complied with all covenants of its debenture agreements and has failed to maintain the required security cover for its listed NCDs. This finding is a critical red flag that would undoubtedly be a focal point for investor scrutiny. The company provided no forward-looking guidance or management outlook with its results.
One-offs:
No exceptional items were reported for the current quarter or the nine-month period. The company had previously reported exceptional items in FY25 due to a fire incident at its Dahej SEZ plant.
🚩 Risks & Outlook
Specific Risks:
The most significant risk stems directly from the auditor's report concerning the listed NCDs. Non-compliance with debt covenants and failure to maintain security cover can lead to:
- Potential default clauses being triggered.
- Demands for immediate repayment or additional security from debenture holders.
- Increased borrowing costs or restricted access to future financing.
- A downgrade in credit ratings.
The consolidated Debt/Equity ratio stood at 1.55x as of December 31, 2025, indicating substantial leverage, which amplifies the risk associated with covenant breaches. The trailing twelve-month Debt Service Coverage Ratio (DSCR) of 1.41x also warrants close monitoring.
The Forward View:
Investors should closely watch for any communication from Neogen Chemicals regarding its plan to rectify the covenant non-compliance and restore security cover for its NCDs. The company's ability to manage its debt obligations and regain market confidence will be crucial in the coming quarters. The lack of management guidance adds a layer of uncertainty regarding future performance trends and strategic direction.